Adrenal adenomas were associated with attenuated weight loss among patients with obesity or overweight using GLP-1 or GIP/GLP-1 RAs.

Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...

Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...

Aptar CSP Technologies has developed a dual-active material science technology designed to simultaneously control moisture ...

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased ...

More employers will likely reduce benefits in 2026 as they try to control fast-growing health benefit costs, with more than half (51%) of large employers (those with 500 or more employees) saying they ...

For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs).

KANSAS CITY — The concept of food as medicine is catching on among consumers who are taking health and wellness into their ...